Berlin, Germany, May 30, 2023, 08:00 CEST – TME Pharma NV (Euronext Growth Paris: ALTME), a biotechnology company specializing in the development of novel therapies for the treatment of cancer by targeting the tumor microenvironment (TME), today announces convene the Company’s Annual General Meeting of Shareholders (the AGM) on June 29, 2023, at 1:30 p.m. CEST, at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, The Netherlands.
To receive all of the company’s financial communications in real time, please register directly by email at the following address: [email protected]